Asthma Control and Asthma Medication Use among Swedish Elite Endurance Athletes

Table 3

Level and distribution of asthma control in a health care-based reference group of patients with current asthma who have never smoked.

	Uncontrolled	Partially controlled	Well controlled	value
Females	55 (67)	35 (61)	67 (66)	0.779
Age (years), mean (SD)	24.1 (4.2)	25.6 (4.7)	26.7 (7.8)	0.006
Age of asthma onset (years), mean (SD)	7.9 (6.2)	9.7 (7.6)	11.3 (6.3)	0.003
Allergy	69 (84)	42 (74)	74 (73)	0.148
Training (hours/week), mean (SD)	5.0 (5.5)	5.3 (4.4)	4.7 (3.7)	0.827
Shortness of breath^1	48 (59)	21 (38)	24 (24)	<0.001
Health care contacts^2	39 (48)	15 (26)	20 (20)	<0.001
Family history of asthma	46 (61)	32 (62)	54 (56)	0.739
Daily SABA/LABA	50 (61)	14 (25)	8 (8)	<0.001
Daily ICS	26 (32)	13 (23)	17 (17)	0.056
Daily ICS + LABA	36 (44)	13 (23)	38 (37)	0.037

The data are presented as n (%) unless otherwise stated; significant values are shown in bold; ¹shortness of breath following strenuous exercise in the previous 12 months; ²respiratory-related health care contacts in the previous 12 months; ICS, inhaled corticosteroids; SABA/LABA, short-acting β2-agonists/long-acting β2-agonists; SD, standard deviation; Pearson’s chi-squared test.